CVRx (CVRX) Competitors $7.56 -0.40 (-5.03%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$7.90 +0.35 (+4.56%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. KMTS, IRMD, SIBN, BBNX, EMBC, SMLR, CBLL, KIDS, AVNS, and BVSShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Beta Bionics (BBNX), Embecta (EMBC), Semler Scientific (SMLR), CeriBell (CBLL), OrthoPediatrics (KIDS), AVANOS MEDICAL (AVNS), and Bioventus (BVS). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors Kestra Medical Technologies iRadimed SiBone Beta Bionics Embecta Semler Scientific CeriBell OrthoPediatrics AVANOS MEDICAL Bioventus Kestra Medical Technologies (NASDAQ:KMTS) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends. Do insiders & institutionals have more ownership in KMTS or CVRX? 75.3% of CVRx shares are held by institutional investors. 3.6% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 13.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher valuation & earnings, KMTS or CVRX? CVRx has lower revenue, but higher earnings than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKestra Medical Technologies$59.82M13.20-$113.81MN/AN/ACVRx$51.29M3.84-$59.97M-$2.18-3.47 Do analysts recommend KMTS or CVRX? Kestra Medical Technologies presently has a consensus target price of $27.33, suggesting a potential upside of 77.72%. CVRx has a consensus target price of $14.50, suggesting a potential upside of 91.80%. Given CVRx's stronger consensus rating and higher probable upside, analysts clearly believe CVRx is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86 Is KMTS or CVRX more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to CVRx's net margin of -97.49%. Kestra Medical Technologies' return on equity of 0.00% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets Kestra Medical TechnologiesN/A N/A N/A CVRx -97.49%-79.04%-42.37% Does the media refer more to KMTS or CVRX? In the previous week, CVRx had 2 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 3 mentions for CVRx and 1 mentions for Kestra Medical Technologies. CVRx's average media sentiment score of 0.00 beat Kestra Medical Technologies' score of 0.00 indicating that CVRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCVRx beats Kestra Medical Technologies on 8 of the 13 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$207.54M$6.77B$5.47B$9.53BDividend YieldN/A1.32%4.74%4.08%P/E Ratio-3.4720.9428.6723.80Price / Sales3.8459.01422.3188.12Price / CashN/A20.5035.4557.96Price / Book2.584.468.275.55Net Income-$59.97M$174.54M$3.24B$259.03M7 Day Performance-9.35%-5.27%-3.63%-4.56%1 Month Performance17.03%-3.94%4.40%4.49%1 Year Performance-8.14%8.26%25.97%18.05% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.6801 of 5 stars$7.56-5.0%$14.50+91.8%-8.9%$207.54M$51.29M-3.47160Upcoming EarningsKMTSKestra Medical Technologies0.9765 of 5 stars$16.63+4.6%$27.33+64.4%N/A$816.44M$59.81M0.00300IRMDiRadimed4.1857 of 5 stars$56.19-0.9%$72.00+28.1%+43.4%$720.81M$75.15M36.25110News CoverageEarnings ReportDividend AnnouncementGap UpSIBNSiBone3.9258 of 5 stars$16.67+0.3%$22.50+35.0%+17.2%$708.25M$167.18M-26.05350Upcoming EarningsBBNXBeta Bionics2.3438 of 5 stars$14.30+5.2%$23.44+63.9%N/A$589.21M$65.12M0.00294Trending NewsEarnings ReportAnalyst ForecastLockup ExpirationAnalyst RevisionEMBCEmbecta4.6464 of 5 stars$10.29+5.2%$19.00+84.6%-35.3%$571.57M$1.12B11.432,100News CoverageUpcoming EarningsSMLRSemler Scientific2.5482 of 5 stars$39.67-3.8%$89.00+124.4%+14.4%$568.63M$56.29M-15.20120Upcoming EarningsGap DownCBLLCeriBell2.2299 of 5 stars$15.21-2.4%$32.14+111.3%N/A$563.11M$65.44M0.00N/AKIDSOrthoPediatrics3.7468 of 5 stars$21.88-0.6%$35.83+63.8%-33.2%$534.56M$212.45M-12.50200News CoverageUpcoming EarningsAVNSAVANOS MEDICAL2.3241 of 5 stars$11.40+1.6%N/A-53.7%$518.86M$687.80M-1.362,227News CoverageUpcoming EarningsBVSBioventus3.1318 of 5 stars$6.30+0.6%$13.75+118.3%-11.7%$517.51M$567.70M-10.331,200 Related Companies and Tools Related Companies KMTS Competitors IRMD Competitors SIBN Competitors BBNX Competitors EMBC Competitors SMLR Competitors CBLL Competitors KIDS Competitors AVNS Competitors BVS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
